Chitosan nanocapsules as carriers for oral peptide delivery: Effect of chitosan molecular weight and type of salt on the in vitro behaviour and in vivo effectiveness

Journal of Nanoscience and Nanotechnology

Volumn 6, Issue 9-10, 2006, Pages 2921-2928

  Prego, C ^a   Torres, D ^a   Alonso, M J ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Caco 2 Cell Culture; Chitosan Nanocapsules; Chitosan Properties; Oral Efficacy

Indexed keywords

CACO-2 CELL CULTURE; CHITOSAN NANOCAPSULES; CHITOSAN PROPERTIES; ORAL EFFICACY;

CALCIUM; CELL CULTURE; ELECTRIC RESISTANCE; MOLECULAR WEIGHT;

NANOSTRUCTURED MATERIALS;

CALCITONIN; CALCIUM; CHITOSAN; DRUG CARRIER; INORGANIC SALT; NANOMATERIAL; PEPTIDE HORMONE;

ANIMAL; ARTICLE; BLOOD; CELL STRAIN CACO 2; CELL SURVIVAL; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; HUMAN; MALE; MATERIALS TESTING; MICROCAPSULE; MOLECULAR WEIGHT; ORAL DRUG ADMINISTRATION; PARTICLE SIZE; RAT; SPRAGUE DAWLEY RAT;

ADMINISTRATION, ORAL; ANIMALS; CACO-2 CELLS; CALCITONIN; CALCIUM; CAPSULES; CELL SURVIVAL; CHITOSAN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG CARRIERS; HUMANS; MALE; MATERIALS TESTING; MOLECULAR WEIGHT; NANOSTRUCTURES; PARTICLE SIZE; PEPTIDE HORMONES; RATS; RATS, SPRAGUE-DAWLEY; SALTS;

EID: 33750059489     PISSN: 15334880     EISSN: None     Source Type: Journal    
DOI: 10.1166/jnn.2006.429     Document Type: Conference Paper

References (38)

1. S. Clement, P. Dandona, J. G. Still, and G. Kosutic, Metabolism 53, 54 (2004).
2. B. N. Singh and S. Majuru, Drug Deliv. Technol. 3, 58 (2003).
3. N. M. Mehta, Bio. Pharm. Int. 17, 38 (2004).
4. E. Mathiowitz, J. S. Jacob, Y. S. Jong, G. P. Carino, D. E. Chickering, K. Vijayaraghavan, S. Montgomery, M. Bassett, and C. Morrell, Nature 386, 410 (1997).
5. Y. Jiao, N. Ubrich, M. Marchand-Arvier, C. Vigneron, M. Hoffman, T. Lecompte, and P. Maincent, Circulation 105, 230 (2002).
6. A. Vila, A. Sanchez, M. Tobio, P. Calvo, and M. J. Alonso, J. Control. Rel. 78, 15 (2002).
7. F. A. Dorkoosh, J. C. Verhoef, M. Rafiee-Tehrani, G. Borchard, and H. E. Junginger, S. T. P. Pharma. Sci. 12, 213 (2002).
8. C. Damge, C. Michel, M. Aprahamian, and P. Couvreur, Diabetes 37, 246 (1988).
9. M. P. Desai, V. Labhasetwar, G. L. Amidon, and R. J. Levy, Pharm. Res. 13, 1838 (1996).
10. A. T. Florence, Pharm. Res. 14, 259 (1997).
11. A. Aseentiis, J. L. deGrazia, C. N. Bowman, P. Colombo, and N. A. Peppas, J. Control. Rel. 33, 197 (1995).
12. Y. Kawashima, H. Yamamoto, H. Takeuchi, and Y. Kuno, Pharm. Dev. Technol. 5, 77 (2000).
13. S. Sakuma, N. Suzuki, R. Sudo, K. Hiwatari, A. Kishida, and M. Akashi, Int. J. Pharm. 239, 185 (2002).
14. C. Prego, D. Torres, and M. J. Alonso, Exp. Opt. Drug Deliv. 2, 843 (2005).
15. K. A. Janes, P. Calvo, and M. J. Alonso, Adv. Drug Deliv. Rev. 47, 83 (2001).
16. Y. Pan, Y. Li, H. Zhao, J. Zheng, H. Xu, G. Wei, J. Hao, and F. Cui, Int. J. Pharm. 249, 139 (2002).
17. Z. Ma, T. M. Lim, and L. Y. Lim, Pharm. Nanotechnol. 293, 271 (2005).
18. H. Takeuchi, Y. Matsui, H. Yamamoto, and Y. Kawashima, J. Control. Rel. 86, 235 (2003).
19. M. Garcia-Fuentes, C. Prego, D. Torres, and M. J. Alonso, Eur. J. Pharm. Sci. 25, 133 (2005).
20. P. Calvo, J. L. Vila-Jato, and M. J. Alonso, Int. J. Pharm. 153, 41 (1997).
21. R. Fernández-Urrusuno, P. Calvo, C. Remuñán- López, J. L. Vila-Jato, and M. J. Alonso, Pharm. Res. 16, 1576 (1999).
22. C. Prego, M. García, D. Torres, and M. J. Alonso, J. Control. Rel. 101, 151 (2005).
23. C. M. Lehr, J. A. Bouwstra, E. H. Schacht, and H. E. Junginger, Int. J. Pharm. 78, 43 (1992).
24. P. Artursson, T. Lindmark, S. S. Davis, and L. Ilium, Pharm. Res. 11, 1358 (1994).
25. N. G. M. Schipper, K. M. Varum, and P. Artursson, Pharm. Res. 13, 1686 (1996).
26. S. Y. Chae, M. Jang, and J. Nah, J. Control. Rel. 102, 383 (2005).
27. A. F. Kotze, B. J. de Leeuw, H. L. Luessen, A. G. de Boer, J. C. Verhoef, and H. E. Junginger, Int. J. Pharm. 159, 243 (1997).
28. M. Huang, E. Khor, and L. Lim, Pharm. Res. 21, 344 (2004).
29. B. Carreno-Gomez and R. Duncan, Int. J. Pharm. 148, 231 (1997).
30. T. J. Aspden, L. Illum, and O. Skaugrud, Eur. J. Pharm. Sci. 4, 23 (1996).
31. A. Vila, A. Sanchez, K. Janes, I. Behrens, T. Kissel, J. L. Vila-Jato, and M. J. Alonso, Eur. J. Pharm. Biopharm. 57, 123 (2004).
32. C. Prego, D. Torres, and M. J. Alonso, Chitosan Nanocapsules: New Carriers for Nasal Peptide Delivery (accepted).
33. P. Calvo, C. Remuñán-Lopez, J. L. Vila-Jato, and M. J. Alonso, Colloid. Polym. Sci. 275, 46 (1997).
34. S. Ogawa, E. A. Decker, and D. J. McClements, J. Agric. Food Chem. 51, 2806 (2003).
35. K. C. Lee, Y. J. Lee, H. M. Song, C. J. Chun, and P. P. DeLuca, Pharm. Res. 9, 1521 (1992).
36. V. Dodane, M. A. Khan, and J. R. Merwin, Int. J. Pharm. 182, 21 (1999).
37. J. Smith, E. Wood, and M. Dornish, Pharm. Res. 21, 43 (2004).
38. N. G. M. Schipper, S. Olsson, J. A. Hoogstraate, A. G. deBoer, K. M. Varum, and P. Artursson, Pharm. Res. 14, 923 (1997).